google1cd7abaa8d26ae66.html

Copy of Video Banner (4).png

2020 CONFERENCE VIDEO ARCHIVE

PRACTITIONER ONLY

GENOSTICS CANCER CONFERENCE 2020

Know Your Options IV

Evidence-based adjunctive therapies for cancer patients

Featured

Convenor of the Genostics Cancer Conference 2020

Prof David Bell

TESTING CTCS FOR PROGNOSTIC AND THERAPY RELEVANT MARKERS

Dr Joachim Fluhrer

META ANALYSIS OF 15 YEAR DATA: CTCS AS HIGHLY SIGNIFICANT PROGNOSTIC INDICATOR

Prof Katharina Pachmann

CANCER AND VITAMIN C. CURRENT TRIALS AND MECHANISMS OF ACTION

Dr Ian Dettman

Immunoscore for Colon Cancer

Dr Marjane Le Bagousse

CANCER, NK ACTIVITY AND LIFESTYLE: HOW DO THEY RELATE?

Prof Ross Grant

Cannabis Results of Clinical Trial

Prof. Luis Vitetta

A HOLISTIC MOLECULAR PERSPECTIVE OF CANCER DEVELOPMENT

Annemaree Miller

IMMUNE SYSTEM. REVISION AND CHANGES WITH CHRONIC DISEASE

Dr Mark Donohoe

PHYTOCHEMICAL INTERVENTIONS IN THE CANCER PATIENT - AN UNRESOLVED DILEMMA

Dr Christine Houghton

SAFETY AND TOLERABILITY OF PROBIOTICS DURING CHEMOTHERAPY

Michael Thomsen (PhD candidate)

HERBAL EXTRACTS AND SYNTHETIC FORMULATIONS FOR I.V. CANCER THERAPIES: IV CURCUMIN IN BREAST CANCER. RESULTS OF A PROSPECTIVE CLINICAL TRIAL

Dr Jürgen Arnhold

HYPERTHERMIA IN ADDITION TO RADIOTHERAPY

A/Prof Michael Jackson

Dr Barbara Fougere

Dr Barbara Fougere

IMMUNOTHERAPY WITH DC VACCINES

Dr Thomas Nesselhut

INDIVIDUALISED CANCER THERAPY: COMBINATION OF GENE-THERAPY, VACCINES, CYTOTOXIC AND BOTANICAL THERAPY

Dr Asir Kopic

CTCS AND NK CELLS

A/Prof Eugen Molodysky

INTERVENTIONAL ONCOLOGY TRENDS AND UPDATE. TARGETED CANCER THERAPY. TACE, TUMOUR PERFUSION AND EMBOLISATION

Prof Thomas Vogl

C2 Smoothie

Genostics